![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1732979
¼¼°èÀÇ ½ÉÀå Æó¼â ±â±â ½ÃÀå : »ê¾÷ ±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ, ¿¹Ãø - Æó¼â À¯Çüº°(¼±Ãµ¼º ½É°á¼ÕÆó¼â{¼ö±âº°(ASD,PDA,VSD), PFO Æó¼â, LAA Æó¼â), Áö¿ªº° ºÎ¹® ¹× °æÀï(2020-2030³â)Heart Closure Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Closure Type (Congenital Heart Defect Closure{By Technique( ASD,PDA,VSD)},PFO Closure, LAA Closure) By Region and Competition, 2020-2030F |
¼¼°èÀÇ ½ÉÀå Æó¼â ±â±â ½ÃÀåÀº 2024³â¿¡ 28¾ï 4,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, ¿¹Ãø ±â°£ µ¿¾È CAGR 10.39%·Î ¼ºÀåÇÒ Àü¸ÁÀ̸ç, 2030³â¿¡´Â 51¾ï 4,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
½ÉÀå Æó¼â ±â±â´Â ½É¹æÁ߰ݰá¼ÕÁõ(ASD), ³¿ø°ø°³Á¸Áõ(PFO), ½É½ÇÁ߰ݰá¼ÕÁõ(VSD) µîÀÇ ±¸Á¶Àû ½ÉÀå °áÇÔÀ» Ä¡·áÇϱâ À§ÇØ ¼³°èµÇ¾úÀ¸¸ç °³½É¼úÀ» ´ëüÇÏ´Â Àúħ½À ´ëü ÀǷḦ Á¦°øÇÕ´Ï´Ù. ½ÉÇ÷°ü ÁúȯÀÇ À¯º´·ü »ó½Â, Ä«Å×Å͸¦ ÀÌ¿ëÇÑ ¼ö¼úÀÇ Ã¤¿ë Áõ°¡, µð¹ÙÀ̽º Àç·á³ª ¼³°èÀÇ Áøº¸, ³ëÀÎ Àα¸ Áõ°¡¿¡ ÀÇÇØ ½ÃÀåÀº ±Þ¼ÓÇÏ°Ô È®´ëµÇ°í ÀÖ½À´Ï´Ù. °æ Ä«Å×ÅÍÀû Æó¼â ±â±â ¹× °ÈµÈ È»ó ±â¼ú µîÀÇ ±â¼ú Çõ½ÅÀº, ÀÌ·¯ÇÑ ¼ö±â¸¦ º¸´Ù Á¤È®Çϰí Àúħ½ÀÀ¸·Î ÇØ, ä¿ëÀ» ÇÑÃþ ´õ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¿Ü»óÀÌ ÀûÀº Ä¡·á¿Í ȯÀÚÀÇ Àü±Í °³¼±À» ¿ä±¸ÇÏ´Â ¼¼°èÀÇ ¿òÁ÷ÀÓÀº ƯÈ÷ ÇコÄɾî ÀÎÇÁ¶ó°¡ ¹ß´ÞÇÏ°í ½ÉÀå°áÇÔ Ä¡·á¿¡ ´ëÇÑ ÀǽÄÀÌ ³ô¾ÆÁö°í ÀÖ´Â Áö¿ª¿¡¼ ÀÌµé ±â±â¿¡ ´ëÇÑ ¼ö¿ä¸¦ Áö¼ÓÀûÀ¸·Î ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
½ÃÀå °³¿ä | |
---|---|
¿¹Ãø ±â°£ | 2026-2030³â |
½ÃÀå ±Ô¸ð(2024³â) | 28¾ï 4,000¸¸ ´Þ·¯ |
½ÃÀå ±Ô¸ð(2030³â) | 51¾ï 4,000¸¸ ´Þ·¯ |
CAGR(2025-2030³â) | 10.39% |
±Þ¼ºÀå ºÎ¹® | CHD Ŭ·ÎÀú |
ÃÖ´ë ½ÃÀå | ºÏ¹Ì |
±â¼ú Áøº¸
»óȯ ¹®Á¦
°æ Ä«Å×ÅÍ Æó¼â ±â±â
The Global Heart Closure Devices Market was valued at USD 2.84 billion in 2024 and is projected to reach USD 5.14 billion by 2030, growing at a CAGR of 10.39% during the forecast period. Heart closure devices are designed to treat structural heart defects such as atrial septal defects (ASDs), patent foramen ovale (PFO), and ventricular septal defects (VSD), providing a minimally invasive alternative to open-heart surgery. The market is expanding rapidly due to the rising prevalence of cardiovascular conditions, increasing adoption of catheter-based procedures, advancements in device materials and design, and the growing geriatric population. Technological innovations, such as transcatheter closure devices and enhanced imaging techniques, are making these procedures more precise and less invasive, further driving adoption. The global push for less traumatic interventions and improved patient outcomes continues to fuel demand for these devices, especially in regions with advanced healthcare infrastructure and rising awareness about heart defect treatments.
Market Overview | |
---|---|
Forecast Period | 2026-2030 |
Market Size 2024 | USD 2.84 Billion |
Market Size 2030 | USD 5.14 Billion |
CAGR 2025-2030 | 10.39% |
Fastest Growing Segment | CHD Closure |
Largest Market | North America |
Key Market Drivers
Technological Advancements
Technological progress has significantly contributed to the expansion of the heart closure devices market. Developments in biomaterials and engineering have led to devices that are smaller, more flexible, and easier to implant, improving patient comfort and clinical outcomes. Innovations in catheter-based techniques enable minimally invasive procedures, reducing recovery time and surgical risks. Additionally, the integration of real-time imaging technologies such as 3D imaging and intracardiac echocardiography (ICE) allows for accurate visualization and placement of closure devices. These advancements have expanded treatment options for patients with congenital or acquired heart defects and have made these procedures more accessible and safer, which has helped boost overall market growth.
Key Market Challenges
Reimbursement Issues
Inconsistent and limited reimbursement policies represent a significant challenge in the heart closure devices market. Coverage and reimbursement vary widely across countries and healthcare systems, influencing patient access and the financial viability of procedures. In regions where reimbursement is limited or unclear, patients may face high out-of-pocket costs, deterring them from undergoing treatment. Healthcare providers also encounter administrative burdens and delays in securing reimbursement, which can limit their ability to offer these procedures consistently. These factors create disparities in treatment availability and restrict the adoption of heart closure devices, particularly in lower-income or publicly funded healthcare environments.
Key Market Trends
Transcatheter Closure Devices
Transcatheter closure devices are gaining prominence as the preferred approach for treating structural heart defects. These devices are delivered through catheters, offering a highly targeted and minimally invasive method of closure that reduces surgical complications and shortens recovery time. As precision and ease-of-use improve, these devices are increasingly seen as the standard of care, particularly for conditions like PFO and ASDs. Advanced delivery systems and real-time imaging facilitate accurate deployment, contributing to better procedural outcomes. The growing demand for less invasive cardiac procedures, combined with strong clinical efficacy, is driving widespread adoption of transcatheter closure technologies and accelerating their market penetration.
Report Scope
In this report, the Global Heart Closure Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Heart Closure Devices Market.
Available Customizations
Global Heart Closure Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: